Latest News- Infectious Disease Market: Drugs is expected to lead the Product segment during 2025-2029

The Infectious Disease Market is being driven by Increasing prevalence of infectious diseases

The Infectious Disease Market is expected to grow at a CAGR of 14.7% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 160.8 billion. In the realm of infectious diseases, the biopharmaceutical industry is witnessing a surge in research and development of innovative treatments. For instance, researchers at the Indian Institute of Science have made a significant breakthrough in the fight against tuberculosis. They have discovered a novel drug combination, which includes pranlukast, that shows promising results in improving treatment outcomes. The bacterium responsible for tuberculosis is notorious for developing resistance against new drugs, making the discovery of effective treatment options crucial. Pranlukast is believed to not only kill the tuberculosis bacterium but also compromise its survival mechanisms within cells. This groundbreaking discovery opens up new opportunities for the development of effective therapeutics against tuberculosis. Additionally, researchers at the University of Otago, New Zealand, have made strides in the field of infectious diseases by discovering a potential new antiviral compound. This compound, which is currently in the preclinical stage, holds the potential to combat a range of viral infections. The ongoing research and development in this area underscore the importance of continued investment in the infectious disease market. 

Get more information on Infectious Disease Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Product
  • Drugs
  • Vaccines
• End-user
  • Hospital
  • Multispecialty clinic
  • Others
• Type
  • Bacterial infections
  • Viral infections
  • Fungal infections
  • Parasitic infections
• Geography
  • North America
    • Canada
    • US
  • Europe
    • Germany
    • UK
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Increasing prevalence of infectious diseases
• Growing awareness of infectious diseases
• Strong drug pipeline

However, the market also witnesses some limitations, which are as follows:

• Adverse effects of anti-infective drugs
• Availability of counterfeit drugs
• Anti-microbial resistance (AMR) of pathogens

Benefits of Buying Global Infectious Disease Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in Infectious Disease Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The Infectious Disease Market is witnessing significant growth due to the increasing demand for Point-of-Care (PoC) diagnostic testing that offers rapid results for urgent diagnosis in various healthcare settings such as urgent care centers, emergency rooms, and ambulances. This prompt diagnosis is crucial for effective infection control and improving patient outcomes in the face of inadequate infrastructure, poor water sanitation, and rising cases of infectious diseases like hepatitis, syphilis, mosquito-borne diseases, gonorrhea, RNA viruses, and more. Healthcare professionals require adequate training to use advanced diagnostic tools like immunodiagnostics, clinical microbiology, DNA sequencing, Next-Generation Sequencing (NGS), and DNA Microarray for accurate diagnosis. These technologies play a vital role in identifying and combating various infectious diseases, ensuring personal health and hygiene, and addressing the challenges of inadequate infrastructure and poor water sanitation.

Market Research Overview

The Infectious Disease Market encompasses diagnostic testing solutions that offer rapid results for prompt diagnosis in various healthcare settings, including urgent care centers, emergency rooms, and ambulances. Point-of-care testing plays a pivotal role in improving patient outcomes and infection control, particularly in the context of personal health and hygiene. The global Pharmaceuticals Market, a segment of the larger healthcare industry, is projected to expand significantly due to several factors. One such factor is the increasing aging population, with Europe and the US forecasted to have nearly one-quarter of their populations aged 60 and above by 2030 and 2050, respectively. This demographic shift will fuel the demand for pharmaceutical solutions, including those related to infectious diseases. Technavio, a leading market research firm, calculates the healthcare market size based on the combined revenue generated by manufacturers and providers of equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/